Vicapsys Life Sciences, Inc.
Data quality: 83%
VICP
OTC
Manufacturing
Chemicals
$1.46
$0.00
(0.00%)
Mkt Cap: 47.26 M
Price
$1.46
Mkt Cap
47.26 M
Day Range
$0.51 — $0.51
52-Week Range
$0.15 — $1.77
Volume
100
Open $0.51
50D / 200D Avg
$1.44
1.52% above
50D / 200D Avg
$1.60
8.48% below
Quick Summary
Key Takeaways
Negative free cash flow of -125,741.0
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
N/A
ROICN/A
Net MarginN/A
Op. MarginN/A
Safety
Debt / Equity
N/A
Current Ratio0.03
Interest Coverage-14.65
Valuation
PE (TTM)
-35.07
Below sector avg (-1.98)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A
Price History
Financial Trends
Peer Comparison
vs Manufacturing sector median (44 peers)
Peer Comparison
vs Manufacturing sector median (44 peers)| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -35.1 | -2.0 |
| P/B | — | 5.1 |
| ROE % | — | -51.0 |
| Net Margin % | — | -150.2 |
| Rev Growth 5Y % | — | 9.3 |
| D/E | — | 0.3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | N/A | Net Income (TTM) | -1.35 M |
| ROE | N/A | ROA | -2085.47% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -125,741.0 |
| ROIC | N/A | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 0.03 |
| Interest Coverage | -14.65 | Asset Turnover | N/A |
| Working Capital | -2.65 M | Tangible Book Value | -2.65 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -35.07 | Forward P/E | N/A |
| P/B Ratio | N/A | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -0.27% | ||
| Market Cap | 47.26 M | Enterprise Value | 47.17 M |
| Per Share | |||
| EPS (Diluted TTM) | -0.03 | Revenue / Share | N/A |
| FCF / Share | 0.00 | OCF / Share | 0.00 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 9.33% |
| SBC-Adj. FCF | -146,438 | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|
| Revenue | — | — | — | — |
| Net Income | -1.18 M | -984,790.0 | -236,871.0 | -765,844.0 |
| EPS (Diluted) | -0.03 | — | — | — |
| Gross Profit | — | — | — | — |
| Operating Income | -1.05 M | -984,790.0 | -336,871.0 | — |
| EBITDA | — | — | — | — |
| R&D Expenses | 15,267.0 | 13,097.0 | 17,698.0 | 102,180.0 |
| SG&A Expenses | — | — | — | — |
| D&A | — | — | — | — |
| Interest Expense | 5,156.0 | — | — | — |
| Income Tax | — | — | — | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|
| Total Assets | 39,656.0 | 72,021.0 | 594,313.0 | 404,118.0 |
| Total Liabilities | — | — | — | — |
| Shareholders' Equity | -1.93 M | -950,791.0 | -121,651.0 | -449,106.0 |
| Total Debt | 18,712.0 | — | — | — |
| Cash & Equivalents | 9,422.0 | 14,097.0 | 217,295.0 | 1,269.0 |
| Current Assets | 39,656.0 | 72,021.0 | 222,793.0 | 1,269.0 |
| Current Liabilities | 1.97 M | 1.02 M | 715,964.0 | 853,224.0 |
{"event":"ticker_viewed","properties":{"ticker":"VICP","listing_kind":"stock","pathname":"/stocks/vicp","exchange":"OTC","country":"US"}}